participant,SRS2_resp,SRS2_RT,SRS2_item,SRS2_scoring_type,SRS2_treatment_subscale
113,2,15.8857,1,positive,mot
113,2,8.6925,2,positive,awr
113,4,12.246,3,negative,mot
113,2,9.802,4,positive,rrb
113,3,6.4828,5,positive,cog
113,2,4.6613,6,positive,mot
113,2,5.2781,7,negative,awr
113,3,4.302,8,positive,rrb
113,2,6.3684,9,positive,mot
113,2,10.5303,10,positive,cog
113,2,5.0485,11,negative,mot
113,2,6.3288,12,negative,com
113,1,13.2044,13,positive,com
113,3,5.4961,14,positive,rrb
113,2,6.8159,15,negative,cog
113,2,7.1629,16,positive,com
113,2,6.7224,17,negative,cog
113,1,5.2058,18,positive,com
113,2,4.8424,19,positive,com
113,2,9.9635,20,positive,rrb
113,2,6.3912,21,negative,com
113,3,4.0654,22,negative,com
113,2,5.3748,23,positive,mot
113,2,11.7346,24,positive,rrb
113,3,7.1335,25,positive,awr
113,3,5.5369,26,negative,com
113,2,7.0627,27,positive,mot
113,2,5.0194,28,positive,rrb
113,4,3.6165,29,positive,rrb
113,2,5.4811,30,positive,cog
113,3,4.6484,31,positive,rrb
113,3,2.9713,32,negative,awr
113,2,7.6134,33,positive,com
113,2,12.7437,34,positive,mot
113,2,4.914,35,positive,com
113,2,3.4025,36,positive,com
113,2,4.6777,37,positive,com
113,3,7.3511,38,negative,com
113,2,6.3083,39,positive,rrb
113,3,2.6202,40,negative,cog
113,3,6.565,41,positive,com
113,2,4.8131,42,positive,cog
113,4,2.9028,43,negative,mot
113,2,19.6465,44,positive,cog
113,2,7.4474,45,negative,awr
113,1,4.5832,46,positive,com
113,2,2.2731,47,positive,com
113,3,4.2531,48,negative,cog
113,2,9.6701,49,positive,rrb
113,2,10.0118,50,positive,rrb
113,2,7.5395,51,positive,com
113,2,3.1535,52,positive,awr
113,2,5.742,53,positive,com
113,1,8.136,54,positive,awr
113,2,12.2862,55,positive,com
113,2,14.5817,56,positive,awr
113,3,2.2233,57,positive,com
113,2,6.5102,58,positive,cog
113,2,4.2327,59,positive,cog
113,1,7.6237,60,positive,com
113,2,4.6616,61,positive,com
113,1,7.0504,62,positive,cog
113,3,5.2017,63,positive,rrb
113,2,4.2063,64,positive,mot
113,3,3.6835,65,positive,mot
